BioSpace News Archive

The Company has raised US$26 million in a Series B financing round to scale up its pipeline and advance selected programmes towards clinical development.

• Preparing Three Lead Programs for MLD, ADA-SCID and WAS for Regulatory Filings Over the Next Three Years • Recently Announced Clinical Proof-of-Concept in X-CGD Demonstrates Platform’s Transformative Potential • Advancing Earlier Stage Pipeline with Potential Clinical Proof-of-Concept for TDBT and Clinical Trial Application for MPS-IIIA • Entering 2019 in a Strong Financial Position with $340M in Cash and Investments

Owlet Baby Care Wins Two CES Awards for its New Pregnancy Monitor

Results from Synergy Laboratories’ Diagnostic Tests to be Integrated into SureMed Compliance’s Reporting and Screening Tools

This is a significant achievement for the Company and demonstrates the breadth of Immatics’ innovation power and the quality of its science.

Condition joins list of overlooked diseases requiring immediate treatment in younger adults

Drs. Cotey and Amanda Jordan, of Mars, Pennsylvania, have been able to do what very few headache doctors or specialists have been able to; provide a form of care to Get Rid of Migraines once and for all without ever having to step foot into another hospital or take any more pills!

Axine Water Technologies has signed a multi-year wastewater services agreement with a leading pharmaceutical manufacturer.

The Transportation Safety Board of Canada (TSB) today released its investigation report (R17W0190) into a hi-rail crane boom failure and employee injury that occurred in Brandon, Manitoba, in September 2017

Join Celebrities Jane Lynch, Coby Bell and Others in Raising Funds for the More than 160,000 People with Epilepsy in the Region